Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, +24

Nature Medicine

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

Nicholas Salgia, Paulo Gustavo Bergerot, Manuel Caitano Maia, +8

European Urology

DysbiosisStool Microbiome ProfilingCancer ImmunosurveillanceImmunologyPathology +4

Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis

Sunday S. Oladipupo, Craig Smith, Andrea Santeford, +13

Proceedings of the National Academy of Sciences

Endothelial Cell FgfrSignificance Fgf ReceptorInflammationAngiogenesisFibroblast Growth Factor +18

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma

Rana R. McKay, Dominick Bossé, Wanling Xie, +23

Cancer Immunology Research

The Multicopper Ferroxidase Hephaestin Enhances Intestinal Iron Absorption in Mice

Brie K. Fuqua, Yan Lu, Deepak Darshan, +10

PLoS ONE

NutritionIron MetabolismImmunologyGastroenterologyDigestive Tract +19

National characteristics of Emergency Department visits by patients with cancer in the United States

Joann Hsu, John P. Donnelly, Justin X. Moore, +3

The American Journal of Emergency Medicine

Emergency Department VisitsHealth PolicyMedicinePatient SafetyOutcomes Research +8

Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Tyrosine Kinase Inhibitors

Sumanta K. Pal, Sierra M. Li, Xiwei Wu, +5

Clinical Cancer Research

Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

Nazlı Dizman, Yung Lyou, Nicholas Salgia, +7

Journal for ImmunoTherapy of Cancer

Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma

Nazlı Dizman, Joann Hsu, Paulo Gustavo Bergerot, +6

Cancer Medicine

DysbiosisPathologyProbioticsProbioticOncology +19

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Hedyeh Ebrahimi, Nazlı Dizman, Luís Meza, +26

Nature Medicine